Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Valérie Lamantia"'
Autor:
Simon Bissonnette, Valérie Lamantia, Benjamin Ouimet, Yannick Cyr, Marie Devaux, Remi Rabasa-Lhoret, Michel Chrétien, Maya Saleh, May Faraj
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-18 (2023)
Abstract Elevated plasma numbers of atherogenic apoB-lipoproteins (apoB), mostly as low-density lipoproteins (LDL), predict diabetes risk by unclear mechanisms. Upregulation of the NLRP3 inflammasome/interleukin-1 beta (IL-1β) system in white adipos
Externí odkaz:
https://doaj.org/article/0a83e95703d94c1093fe7679d3611bd4
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 7, p 6130 (2023)
Sex-specific differences exist in insulin secretion (ISec) and sensitivity (IS) in humans. However, current fasting indices used to estimate them, such as HOMA and QUICKI, are not sex-specific. We aimed to develop sex-specific models to improve the p
Externí odkaz:
https://doaj.org/article/8d815065efe64848b6cab3844ca55439
Autor:
Yannick Cyr, Valérie Lamantia, Simon Bissonnette, Melanie Burnette, Aurèle Besse‐Patin, Annie Demers, Martin Wabitsch, Michel Chrétien, Gaétan Mayer, Jennifer L. Estall, Maya Saleh, May Faraj
Publikováno v:
Physiological Reports, Vol 9, Iss 3, Pp n/a-n/a (2021)
Abstract Background LDL‐cholesterol lowering variants that upregulate receptor uptake of LDL, such as in PCSK9 and HMGCR, are associated with diabetes via unclear mechanisms. Activation of the NLRP3 inflammasome/interleukin‐1 beta (IL‐1β) path
Externí odkaz:
https://doaj.org/article/55e8b3a5fa1f4be4a5bf58b8cf9bb904
Autor:
SIMON BISSONNETTE, VALÉRIE LAMANTIA, YANNICK CYR, MARIE DEVAUX, RÉMI RABASA-LHORET, MICHEL CHRETIEN, MAYA SALEH, MAY FARAJ
Publikováno v:
Diabetes. 71
Background and Hypothesis: Elevated plasma apoB-lipoproteins (hyperapoB, mostly LDL) predicts the incidence of type 2 diabetes (T2D) and its risk factors including systemic activation of the interleukin-1 system (measured as plasma IL-1 receptor anta
Autor:
Yannick Cyr, Emmanuelle Loizon, Gaétan Mayer, Valérie Lamantia, Emilienne Tudor Ngo Sock, Simon Bissonnette, Hubert Vidal, Michel Chrétien, Hanny Wassef, May Faraj
Publikováno v:
Obesity
Obesity, Wiley, 2020, 28 (12), pp.2357-2367. ⟨10.1002/oby.22985⟩
Obesity, Wiley, 2020, 28 (12), pp.2357-2367. ⟨10.1002/oby.22985⟩
International audience; Objective Human conditions with upregulated receptor uptake of low-density lipoproteins (LDL) are associated with diabetes risk, the reasons for which remain unexplored. LDL induce metabolic dysfunction in murine adipocytes. T
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 29:504-512
Background and aims Higher fiber intake is associated with increased insulin sensitivity (IS) and reduced glucose-induced insulin secretion (GIIS) during isocaloric-diets; however, its role in hypocaloric-diets is unclear. We examined whether increas
Autor:
Viviane Provost, Christine Des Rosiers, May Faraj, Caroline Daneault, Simon Bissonnette, Valérie Lamantia, Marie Devaux, Yannick Cyr
Publikováno v:
The Journal of Nutrition. 149:57-67
BACKGROUND: δ-5 and δ-6 desaturases (D5D and D6D) catalyze the endogenous conversion of n–3 (ω-3) and n–6 (ω-6) polyunsaturated fatty acids (PUFAs). Their activities are negatively and positively associated with type 2 diabetes (T2D), respect
Autor:
Aurèle Besse-Patin, Jennifer L Estall, Michel Chrétien, Simon Bissonnette, Annie Demers, Valérie Lamantia, May Faraj, Martin Wabitsch, Gaétan Mayer, Melanie Burnette, Yannick Cyr, Maya Saleh
Publikováno v:
Physiological Reports
Physiological Reports, Vol 9, Iss 3, Pp n/a-n/a (2021)
Physiological Reports, Vol 9, Iss 3, Pp n/a-n/a (2021)
Background LDL‐cholesterol lowering variants that upregulate receptor uptake of LDL, such as in PCSK9 and HMGCR, are associated with diabetes via unclear mechanisms. Activation of the NLRP3 inflammasome/interleukin‐1 beta (IL‐1β) pathway promo
Autor:
Yannick Cyr, Aurèle Besse-Patin, Valérie Lamantia, Emmanuelle Meugnier, Simon Bissonnette, Hubert Vidal, Martin Wabitsch, Jennifer L. Estall, May Faraj, Michel Chrétien
Publikováno v:
International Symposium on Atherosclerosis (ISA), Toronto, CANADA, JUN 09-12, 2018
International Symposium on Atherosclerosis (ISA), Toronto, CANADA, JUN 09-12, 2018, Jun 2018, Toronto, Canada. pp.117
International Symposium on Atherosclerosis (ISA), Toronto, CANADA, JUN 09-12, 2018, Jun 2018, Toronto, Canada. pp.117
International Symposium on Atherosclerosis (ISA), Toronto, CANADA, JUN 09-12, 2018; International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f552eaabbd015614f4db4719b2737f9c
https://hal.archives-ouvertes.fr/hal-01980029
https://hal.archives-ouvertes.fr/hal-01980029
Autor:
May Faraj, Nathalie Saint-Pierre, Hanny Wassef, Michel Chrétien, Yannick Cyr, Simon Bissonnette, Valérie Lamantia
Publikováno v:
Journal of Clinical Lipidology. 9:664-675
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) shuttles low-density lipoprotein (LDL) receptors for degradation, thus upregulates LDL plasma clearance. Although PCSK9 loss of function is cardioprotective, its role in metabolic risks